ArticleJournal of gynecologic oncology2021

Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study.

Soo Jin Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.